← Open Payments lookup

MARY WALSH: Open Payments

NPI 1427135284 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,042 in 50 payments from 12 companies in 2025. Trend: 2023 $188 · 2024 $954 · 2025 $1,042

Food & beverage: $1,042
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$173
Neurocrine BioSciences, Inc.6$155
Otsuka America Pharmaceutical, Inc.8$140
Janssen Pharmaceuticals, Inc6$128
Alkermes, Inc.5$118
ABBVIE INC.5$108
Teva Pharmaceuticals USA, Inc.6$108
Lundbeck LLC2$40
Vanda Pharmaceuticals Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: COBENFY, INGREZZA, ARISTADA, VRAYLAR, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across IL — which companies pay providers there.